Literature DB >> 35323961

Enhancing GD2 CAR T-cell therapy with IGF-1R blockade: Are DIPG CAR T cells ready for combinatorial therapy?

Andrea Franson1, Carl Koschmann1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35323961      PMCID: PMC9248381          DOI: 10.1093/neuonc/noac073

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  10 in total

Review 1.  Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma.

Authors:  Kyle Wierzbicki; Karthik Ravi; Andrea Franson; Amy Bruzek; Evan Cantor; Micah Harris; Morgan J Homan; Bernard L Marini; Abed Rahman Kawakibi; Ramya Ravindran; Rodrigo Teodoro; Viveka Nand Yadav; Carl Koschmann
Journal:  Curr Oncol Rep       Date:  2020-02-06       Impact factor: 5.075

2.  Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201.

Authors:  Andrew S Chi; Rohinton S Tarapore; Matthew D Hall; Nicole Shonka; Sharon Gardner; Yoshie Umemura; Ashley Sumrall; Ziad Khatib; Sabine Mueller; Cassie Kline; Wafik Zaky; Soumen Khatua; Shiao-Pei Weathers; Yazmin Odia; Toba N Niazi; Doured Daghistani; Irene Cherrick; David Korones; Matthias A Karajannis; Xiao-Tang Kong; Jane Minturn; Angela Waanders; Isabel Arillaga-Romany; Tracy Batchelor; Patrick Y Wen; Krystal Merdinger; Lee Schalop; Martin Stogniew; Joshua E Allen; Wolfgang Oster; Minesh P Mehta
Journal:  J Neurooncol       Date:  2019-08-27       Impact factor: 4.130

3.  Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq.

Authors:  Mariella G Filbin; Itay Tirosh; Volker Hovestadt; McKenzie L Shaw; Leah E Escalante; Nathan D Mathewson; Cyril Neftel; Nelli Frank; Kristine Pelton; Christine M Hebert; Christine Haberler; Keren Yizhak; Johannes Gojo; Kristof Egervari; Christopher Mount; Peter van Galen; Dennis M Bonal; Quang-De Nguyen; Alexander Beck; Claire Sinai; Thomas Czech; Christian Dorfer; Liliana Goumnerova; Cinzia Lavarino; Angel M Carcaboso; Jaume Mora; Ravindra Mylvaganam; Christina C Luo; Andreas Peyrl; Mara Popović; Amedeo Azizi; Tracy T Batchelor; Matthew P Frosch; Maria Martinez-Lage; Mark W Kieran; Pratiti Bandopadhayay; Rameen Beroukhim; Gerhard Fritsch; Gad Getz; Orit Rozenblatt-Rosen; Kai W Wucherpfennig; David N Louis; Michelle Monje; Irene Slavc; Keith L Ligon; Todd R Golub; Aviv Regev; Bradley E Bernstein; Mario L Suvà
Journal:  Science       Date:  2018-04-20       Impact factor: 47.728

4.  CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma.

Authors:  Andras Heczey; Chrystal U Louis; Barbara Savoldo; Olga Dakhova; April Durett; Bambi Grilley; Hao Liu; Mengfeng F Wu; Zhuyong Mei; Adrian Gee; Birju Mehta; Huimin Zhang; Nadia Mahmood; Haruko Tashiro; Helen E Heslop; Gianpietro Dotti; Cliona M Rooney; Malcolm K Brenner
Journal:  Mol Ther       Date:  2017-06-09       Impact factor: 11.454

5.  Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis.

Authors:  Michael C Jensen; Julie R Park; Nicholas A Vitanza; Adam J Johnson; Ashley L Wilson; Christopher Brown; Jason K Yokoyama; Annette Künkele; Cindy A Chang; Stephanie Rawlings-Rhea; Wenjun Huang; Kristy Seidel; Catherine M Albert; Navin Pinto; Juliane Gust; Laura S Finn; Jeffrey G Ojemann; Jason Wright; Rimas J Orentas; Michael Baldwin; Rebecca A Gardner
Journal:  Nat Med       Date:  2021-07-12       Impact factor: 53.440

6.  Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant.

Authors:  Emmanuel de Billy; Marsha Pellegrino; Domenico Orlando; Giulia Pericoli; Roberta Ferretti; Pietro Businaro; Maria Antonietta Ajmone-Cat; Sabrina Rossi; Lucia Lisa Petrilli; Nicola Maestro; Francesca Diomedi-Camassei; Marco Pezzullo; Cristiano De Stefanis; Paola Bencivenga; Alessia Palma; Rossella Rota; Francesca Del Bufalo; Luca Massimi; Gerrit Weber; Chris Jones; Andrea Carai; Simona Caruso; Biagio De Angelis; Ignazio Caruana; Concetta Quintarelli; Angela Mastronuzzi; Franco Locatelli; Maria Vinci
Journal:  Neuro Oncol       Date:  2022-07-01       Impact factor: 13.029

7.  SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules.

Authors:  Antoine Daina; Olivier Michielin; Vincent Zoete
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

8.  The Role of the Insulin-Like Growth Factor 1 Pathway in Immune Tumor Microenvironment and Its Clinical Ramifications in Gynecologic Malignancies.

Authors:  Muna Alemi Yahya; Shilhav Meisel Sharon; Shay Hantisteanu; Mordechai Hallak; Ilan Bruchim
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-05       Impact factor: 5.555

9.  GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.

Authors:  Robbie G Majzner; Sneha Ramakrishna; Kristen W Yeom; Shabnum Patel; Harshini Chinnasamy; Liora M Schultz; Rebecca M Richards; Li Jiang; Valentin Barsan; Rebecca Mancusi; Anna C Geraghty; Zinaida Good; Aaron Y Mochizuki; Shawn M Gillespie; Angus Martin Shaw Toland; Jasia Mahdi; Agnes Reschke; Esther H Nie; Isabelle J Chau; Maria Caterina Rotiroti; Christopher W Mount; Christina Baggott; Sharon Mavroukakis; Emily Egeler; Jennifer Moon; Courtney Erickson; Sean Green; Michael Kunicki; Michelle Fujimoto; Zach Ehlinger; Warren Reynolds; Sreevidya Kurra; Katherine E Warren; Snehit Prabhu; Hannes Vogel; Lindsey Rasmussen; Timothy T Cornell; Sonia Partap; Paul G Fisher; Cynthia J Campen; Mariella G Filbin; Gerald Grant; Bita Sahaf; Kara L Davis; Steven A Feldman; Crystal L Mackall; Michelle Monje
Journal:  Nature       Date:  2022-02-07       Impact factor: 49.962

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.